These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients. Wang AY; Poon P; Lai FM; Yu L; Choi PC; Lui SF; Li PK Kidney Int; 2001 Apr; 59(4):1520-8. PubMed ID: 11260416 [TBL] [Abstract][Full Text] [Related]
8. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis. Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155 [TBL] [Abstract][Full Text] [Related]
9. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study. van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497 [TBL] [Abstract][Full Text] [Related]
10. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism. Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232 [TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity. Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980 [TBL] [Abstract][Full Text] [Related]
12. The influence of 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene promoter on the incidence, growth and operative risk of abdominal aortic aneurysm. Jones K; Powell J; Brown L; Greenhalgh R; Jormsjö S; Eriksson P Eur J Vasc Endovasc Surg; 2002 May; 23(5):421-5. PubMed ID: 12027469 [TBL] [Abstract][Full Text] [Related]
13. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels. Sogutlu Sari E; Yazici A; Eser B; Erol MK; Kilic A; Ermis SS; Koytak A; Akşit H; Yakut T Cutan Ocul Toxicol; 2014 Dec; 33(4):270-4. PubMed ID: 24446892 [TBL] [Abstract][Full Text] [Related]
14. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167 [TBL] [Abstract][Full Text] [Related]
15. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels. Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442 [TBL] [Abstract][Full Text] [Related]
16. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption. Pérez-Martínez P; Adarraga-Cansino MD; Fernández de la Puebla RA; Blanco-Molina A; Delgado-Lista J; Marín C; Ordovás JM; López-Miranda J; Pérez-Jiménez F Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340 [TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke. Ding J; Nicklas BJ; Fallin MD; de Rekeneire N; Kritchevsky SB; Pahor M; Rodondi N; Li R; Zmuda JM; Harris TB Am Heart J; 2006 Dec; 152(6):1109-15. PubMed ID: 17161063 [TBL] [Abstract][Full Text] [Related]
18. [Relationship between polymorphisms of plasminogen activator inhibitor-1 promoter gene and pulmonary thromboembolism in Chinese Han population]. Zhai ZG; Wang C; Yang YH; Pang BS; Xiao B; Liu YM; Mao YL; Weng XZ Zhonghua Yi Xue Za Zhi; 2006 May; 86(19):1313-7. PubMed ID: 16796899 [TBL] [Abstract][Full Text] [Related]
20. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes. Yenilmez C; Ozdemir Koroglu Z; Kurt H; Yanas M; Colak E; Degirmenci I; Gunes HV J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]